St. Louis-based C2N Diagnostics has developed what it says is the first blood test to help diagnose Alzheimer’s disease. Now it has plans to take the technology global.
C2N Diagnostics has brought its Alzheimer’s blood test to market. Now it wants to expand in St. Louis and beyond.
View Content